Canada markets open in 2 hours 2 minutes

Revelation Biosciences, Inc. (REVB)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.9900-0.0300 (-1.49%)
At close: 04:00PM EDT
2.0500 +0.06 (+3.02%)
After hours: 04:06PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
7,703
4,146
5,377
6,915
Selling General and Administrative
5,800
4,511
5,487
5,036
Total Operating Expenses
13,503
8,657
10,865
11,950
Operating Income or Loss
-13,503
-8,657
-10,865
-11,950
Total Other Income/Expenses Net
-21.927
8,536
34.962
-36.352
Income Before Tax
-13,482
-120.254
-10,830
-11,987
Income from Continuing Operations
-13,482
-120.254
-10,830
-11,987
Net Income
-13,482
-120.254
-10,830
-11,987
Net Income available to common shareholders
-13,482
-120.254
-10,830
-11,987
Basic EPS
-2.10
-0.53
-149.20
-972.41
Diluted EPS
-2.70
-0.53
-149.20
-972.41
Basic Average Shares
127.125
228.64
72.585
12.327
Diluted Average Shares
131.287
228.64
72.585
12.327